The Indian unit of British drugmaker GSK further alleged that Nicholas Healthcare and Akums are also using identical packaging to take adva...

GSK was granted a patent for vilanterol in India in 2007. The patent expires in September 2022.

The unlisted entity has brands like Sensodyne toothpaste, Crocin analgesic and Iodex pain balm. The majority of GSK Consumer’s India portfo...

In India, a host of companies including GalxoSmithKline & Sun Pharma sell over 180 versions of the drug.

British drugmaker will suspend release, distribution and supply of the heartburn drug.

Unilever Plc’s India unit said on December 3 it would merge GSK Consumer with itself in an all-stock deal that will give it access to Horli...

GSK Consumer Healthcare said it will contest an attempt by Steer Engineering to block the transfer of technology that quickens the process ...

GSK chief strategy officer said there is no clause in the deal that HUL has to retain all GSKCH employees.

“GSK is also looking at using a part of the production capacities at the proposed greenfield facility to cater to export markets.”

Glaxo had stopped manufacturing Crocin from September 2012, and had launched the variant 'Crocin Advance' at a higher price.

Lack of health link blamed as Horlicks maker withdraws 4 products in 2 years in newer food segments.

It may be the season of open offers by MNCs. GlaxoSmithKline Consumer started it earlier this year, followed by Unilever and, the latest, M...

National health regulator Drug Controller General of India has asked GlaxoSmithKline to withdraw promotional advertisement for cervical can...

Shares of Dr Reddy’s Laboratories (DRL) touched an intra-day high of Rs 878.70, amid speculation that the Indian drug maker is in prelimina...

Indian drug makers and research cos can join 'patent pool' programme to develope low cost drugs for 16 neglected tropical diseases.

Troubles keep mounting for Satyam Computer Services. Four of its large clients - Citigroup, Merrill Lynch (ML), Novartis and GlaxoSmith Kle...

In a relief to around 2.5 million HIV patients and generic firms like Cipla and Ranbaxy, GlaxosmithKline (GSK) has pulled out the patent ap...